vs
American Well Corp（AMWL）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是American Well Corp的1.3倍（$69.8M vs $55.3M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -45.1%，领先429.1%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -22.1%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -3.6%）
美国烟草公司由J.B.杜克于1890年整合多家美国烟草制造商合并创立，1896年成为道琼斯工业平均指数最初的12支成分股之一。该公司收购了好彩公司及超过200家竞争对手，一度垄断美国烟草行业。1907年美国联邦政府发起反垄断诉讼，最终将该公司分拆为多家企业。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
AMWL vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.3倍
$55.3M
营收增速更快
RIGL
高出43.3%
-22.1%
净利率更高
RIGL
高出429.1%
-45.1%
两年增速更快
RIGL
近两年复合增速
-3.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $55.3M | $69.8M |
| 净利润 | $-24.9M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -45.5% | 33.2% |
| 净利率 | -45.1% | 384.0% |
| 营收同比 | -22.1% | 21.2% |
| 净利润同比 | 41.6% | 1769.2% |
| 每股收益（稀释后） | $-1.53 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMWLRIGL
| Q4 25 | $55.3M | $69.8M | ||
| Q3 25 | $56.3M | $69.5M | ||
| Q2 25 | $70.9M | $101.7M | ||
| Q1 25 | $66.8M | $53.3M | ||
| Q4 24 | $71.0M | $57.6M | ||
| Q3 24 | $61.0M | $55.3M | ||
| Q2 24 | $62.8M | $36.8M | ||
| Q1 24 | $59.5M | $29.5M |
净利润AMWLRIGL
| Q4 25 | $-24.9M | $268.1M | ||
| Q3 25 | $-32.4M | $27.9M | ||
| Q2 25 | $-19.7M | $59.6M | ||
| Q1 25 | $-18.7M | $11.4M | ||
| Q4 24 | $-42.7M | $14.3M | ||
| Q3 24 | $-43.5M | $12.4M | ||
| Q2 24 | $-49.9M | $-1.0M | ||
| Q1 24 | $-72.1M | $-8.2M |
毛利率AMWLRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率AMWLRIGL
| Q4 25 | -45.5% | 33.2% | ||
| Q3 25 | -52.1% | 40.9% | ||
| Q2 25 | -28.7% | 60.1% | ||
| Q1 25 | -45.5% | 23.9% | ||
| Q4 24 | -60.2% | 28.9% | ||
| Q3 24 | -77.6% | 25.4% | ||
| Q2 24 | -83.4% | 1.2% | ||
| Q1 24 | -126.1% | -23.6% |
净利率AMWLRIGL
| Q4 25 | -45.1% | 384.0% | ||
| Q3 25 | -57.5% | 40.2% | ||
| Q2 25 | -27.8% | 58.6% | ||
| Q1 25 | -28.0% | 21.5% | ||
| Q4 24 | -60.1% | 24.9% | ||
| Q3 24 | -71.2% | 22.5% | ||
| Q2 24 | -79.5% | -2.8% | ||
| Q1 24 | -121.1% | -27.9% |
每股收益（稀释后）AMWLRIGL
| Q4 25 | $-1.53 | $14.11 | ||
| Q3 25 | $-2.00 | $1.46 | ||
| Q2 25 | $-1.24 | $3.28 | ||
| Q1 25 | $-1.19 | $0.63 | ||
| Q4 24 | $-2.71 | $0.82 | ||
| Q3 24 | $-2.87 | $0.70 | ||
| Q2 24 | $-3.36 | $-0.06 | ||
| Q1 24 | $-4.94 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $182.3M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $235.6M | $391.5M |
| 总资产 | $323.8M | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资AMWLRIGL
| Q4 25 | $182.3M | $155.0M | ||
| Q3 25 | $200.9M | $137.1M | ||
| Q2 25 | $219.1M | $108.4M | ||
| Q1 25 | $222.4M | $77.1M | ||
| Q4 24 | $228.3M | $77.3M | ||
| Q3 24 | $244.6M | $61.1M | ||
| Q2 24 | $276.9M | $49.1M | ||
| Q1 24 | $308.6M | $49.5M |
总债务AMWLRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益AMWLRIGL
| Q4 25 | $235.6M | $391.5M | ||
| Q3 25 | $254.9M | $117.6M | ||
| Q2 25 | $282.6M | $81.9M | ||
| Q1 25 | $294.0M | $18.6M | ||
| Q4 24 | $304.8M | $3.3M | ||
| Q3 24 | $336.7M | $-14.6M | ||
| Q2 24 | $363.9M | $-29.9M | ||
| Q1 24 | $408.7M | $-31.7M |
总资产AMWLRIGL
| Q4 25 | $323.8M | $513.6M | ||
| Q3 25 | $359.4M | $242.5M | ||
| Q2 25 | $388.7M | $206.7M | ||
| Q1 25 | $419.5M | $176.0M | ||
| Q4 24 | $436.0M | $164.0M | ||
| Q3 24 | $483.0M | $139.4M | ||
| Q2 24 | $507.8M | $128.4M | ||
| Q1 24 | $548.4M | $126.5M |
负债/权益比AMWLRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-17.4M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $-17.4M | — |
| 自由现金流率自由现金流/营收 | -31.4% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMWLRIGL
| Q4 25 | $-17.4M | $22.0M | ||
| Q3 25 | $-18.8M | $24.0M | ||
| Q2 25 | $-4.7M | $30.5M | ||
| Q1 25 | $-25.1M | $-893.0K | ||
| Q4 24 | $-13.4M | $14.5M | ||
| Q3 24 | $-32.4M | $21.7M | ||
| Q2 24 | $-21.8M | $302.0K | ||
| Q1 24 | $-59.8M | $-5.0M |
自由现金流AMWLRIGL
| Q4 25 | $-17.4M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-25.1M | — | ||
| Q4 24 | $-13.4M | — | ||
| Q3 24 | $-32.4M | — | ||
| Q2 24 | $-21.8M | — | ||
| Q1 24 | $-59.8M | — |
自由现金流率AMWLRIGL
| Q4 25 | -31.4% | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -37.6% | — | ||
| Q4 24 | -18.9% | — | ||
| Q3 24 | -53.0% | — | ||
| Q2 24 | -34.7% | — | ||
| Q1 24 | -100.5% | — |
资本支出强度AMWLRIGL
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | — | ||
| Q1 25 | 0.0% | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.0% | — | ||
| Q2 24 | 0.0% | — | ||
| Q1 24 | 0.1% | — |
现金转化率AMWLRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMWL
| Platform Subscription | $28.8M | 52% |
| Visits | $23.7M | 43% |
| Others | $2.8M | 5% |
RIGL
暂无分部数据
